>ABOUT TAKEDA >Message from Top Management
Yasuchika Hasegawa, President & CEO
With the integration of Nycomed, new geographies, and a shift in our business model, Takeda has created a new corporate vision, "Vision 2020," which aims to realize where the company aspires to be in the year 2020.
Vision 2020 – aligned under the key theme of “Better Health, Brighter Future” – consists of three elements: “Our Business: Committed to Improving Health,” “Our Organization: Strength from Diversity,” and “Our People: Powered by Passion.” The goal of Takeda’s business vision specifically is, “We pursue innovative medicines as well as high-quality branded generics, life-saving vaccines, and OTC medicines – to help as many people as we can, as soon as we can.”
Takeda is continuously committed to efforts for achieving further global growth, through the implementation of its new Mid-Range Growth strategy announced today and the shared determination of management and a diverse workforce of approximately 30,000 employees all over the world.
Takeda's corporate mission remains to "strive towards better health for people worldwide through leading innovation in medicine." We will therefore continue to harness intellectual capital from around the world to realize our mission, while seeking to fulfill the expectations of stakeholders by confronting change directly.
I would like thank our customers, shareholders, and all other stakeholders for the strong and constant support you have given us. I hope you will continue to take an interest in Takeda's journey going forward.
May 9, 2013